Non-Hodgkin's lymphoma after liver transplantation: Response to chemotherapy
✍ Scribed by Gallego-Melcón, Soledad; Sánchez de Toledo, José; Martínez, Vicente; Moraga, Fernando; Iglesias, Juan; Ruiz, Carmen; Allende, Elena
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 445 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
✦ Synopsis
An increased incidence of lymphoproliferative disorders in immunosuppressed organ transplant recipients has long been recognised. Lymphoproliferative disorders occur in 2% of orthotopic liver transplant patients. Different therapies have been used, but the optimal treatment remains unknown. Relatively little information is available on experiencewith cytotoxic chemotherapy. Three children who developed Burkitt-like, non-Hodgkin's lymphomas after liver transplantation are described. The disease failed to regress after initial management, which included a reduction in immunosuppression. With cytotoxic chemotherapy all three achieved complete remission, which continued 36+, 35+, and 1 6 f months after diagnosis. Results suggest that in selected cases chemotherapy can be safe in late-onset lymphomas appearing after solid organ transplantation.
📜 SIMILAR VOLUMES
The expression of p53 and PCNA on deparaffinized sections of tumor was assessed in relation to the International Index and response to chemotherapy. Thirty-five non-Hodgkin's lymphoma (NHL) patients were divided into three groups: aggressive NHL, mantle cell lymphoma (MCL), and low-grade NHL. None o